SERA PROGNOSTICS INC-A (SERA) Stock Overview
USA - NASDAQ:SERA - US81749D1072 - Common Stock
SERA Key Statistics, Chart & Performance
The current stock price of SERA is 3.23 USD. In the past month the price decreased by -8.21%. In the past year, price decreased by -56.59%.
SERA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 22.28 | 416.77B | ||
| AMGN | AMGEN INC | 13.68 | 160.60B | ||
| GILD | GILEAD SCIENCES INC | 14.47 | 138.97B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.91 | 103.83B | ||
| REGN | REGENERON PHARMACEUTICALS | 13.29 | 64.30B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 59.66B | ||
| ARGX | ARGENX SE - ADR | 85.83 | 48.69B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.92 | 40.30B | ||
| INSM | INSMED INC | N/A | 33.33B | ||
| BNTX | BIONTECH SE-ADR | N/A | 25.36B | ||
| BIIB | BIOGEN INC | 9.94 | 23.34B | ||
| NTRA | NATERA INC | N/A | 22.62B |
Related stock screener links
About SERA
Company Profile
Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. The company is headquartered in Salt Lake City, Utah and currently employs 63 full-time employees. The company went IPO on 2021-07-15. The company has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found in blood that are accurate predictors of dynamic changes that occur during pregnancy. Its commercial product, the PreTRM test, is a validated, commercially available blood-based biomarker test to predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation that provides a prediction of the expectant mother’s risk of delivering spontaneously before 37 weeks’ gestation.
Company Info
SERA PROGNOSTICS INC-A
2749 E. Parleys Way, Suite 200
Salt Lake City UTAH US
CEO: Gregory C. Critchfield
Employees: 64
Phone: 18015050278
SERA PROGNOSTICS INC-A / SERA FAQ
What is the stock price of SERA PROGNOSTICS INC-A today?
The current stock price of SERA is 3.23 USD. The price increased by 3.19% in the last trading session.
What is the ticker symbol for SERA PROGNOSTICS INC-A stock?
The exchange symbol of SERA PROGNOSTICS INC-A is SERA and it is listed on the Nasdaq exchange.
On which exchange is SERA stock listed?
SERA stock is listed on the Nasdaq exchange.
What is SERA PROGNOSTICS INC-A worth?
SERA PROGNOSTICS INC-A (SERA) has a market capitalization of 122.93M USD. This makes SERA a Micro Cap stock.
How many employees does SERA PROGNOSTICS INC-A have?
SERA PROGNOSTICS INC-A (SERA) currently has 64 employees.
What are the support and resistance levels for SERA PROGNOSTICS INC-A (SERA) stock?
SERA PROGNOSTICS INC-A (SERA) has a support level at 3.12 and a resistance level at 3.21. Check the full technical report for a detailed analysis of SERA support and resistance levels.
Is SERA PROGNOSTICS INC-A (SERA) expected to grow?
The Revenue of SERA PROGNOSTICS INC-A (SERA) is expected to grow by 118.18% in the next year. Check the estimates tab for more information on the SERA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy SERA PROGNOSTICS INC-A (SERA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of SERA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of SERA, evaluating the profitability, health, valuation and growth aspects
- SERA PROGNOSTICS INC-A (SERA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SERA PROGNOSTICS INC-A (SERA) Sales and EPS estimates to see what analysts future expectations are.
- SERA PROGNOSTICS INC-A (SERA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SERA PROGNOSTICS INC-A (SERA) Insider and Institutional Ownership to learn about the owners and their transactions.
- SERA PROGNOSTICS INC-A (SERA) Stock Chart to make your own analysis
- SERA PROGNOSTICS INC-A (SERA) Latest news and press-releases to stay up to date.
Does SERA PROGNOSTICS INC-A (SERA) stock pay dividends?
SERA does not pay a dividend.
When does SERA PROGNOSTICS INC-A (SERA) report earnings?
SERA PROGNOSTICS INC-A (SERA) will report earnings on 2025-11-04, after the market close.
What is the Price/Earnings (PE) ratio of SERA PROGNOSTICS INC-A (SERA)?
SERA PROGNOSTICS INC-A (SERA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.85).
What is the Short Interest ratio of SERA PROGNOSTICS INC-A (SERA) stock?
The outstanding short interest for SERA PROGNOSTICS INC-A (SERA) is 1.93% of its float. Check the ownership tab for more information on the SERA short interest.
SERA Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to SERA. When comparing the yearly performance of all stocks, SERA is a bad performer in the overall market: 85.89% of all stocks are doing better.
SERA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SERA. While SERA seems to be doing ok healthwise, there are quite some concerns on its profitability.
SERA Financial Highlights
Over the last trailing twelve months SERA reported a non-GAAP Earnings per Share(EPS) of -0.85. The EPS increased by 13.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -29.27% | ||
| ROE | -37.1% | ||
| Debt/Equity | 0 |
SERA Forecast & Estimates
For the next year, analysts expect an EPS growth of 21.7% and a revenue growth 118.18% for SERA